UR-ENERGY INC Logo

UR-ENERGY INC

A U.S. uranium mining company using ISR methods to produce fuel for the clean nuclear power market.

URG | NYSE

Overview

Corporate Details

ISIN(s):
CA91688R1082
LEI:
Country:
United States of America
Address:
SUITE 200, 80127 LITTLETON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ur-Energy Inc. is a U.S.-based uranium exploration and mining company engaged in the acquisition, development, and operation of uranium mineral properties. The company specializes in uranium recovery and processing, primarily employing in situ recovery (ISR) methods to maintain a minimal environmental footprint. Its flagship operational asset is the Lost Creek Project in Wyoming, which has been in production for over nine years. Ur-Energy also holds other projects, including the construction-ready Shirley Basin uranium project in Wyoming and the Excel gold exploration project in Nevada. The company produces uranium to supply the clean nuclear fuel market for power generation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all UR-ENERGY INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for UR-ENERGY INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for UR-ENERGY INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154

Talk to a Data Expert

Have a question? We'll get back to you promptly.